Arch Therapeutics Price Patterns

ARTHDelisted Stock  USD 0.0001  0.00  0.00%   
As of 13th of February 2026 the relative strength index (rsi) of Arch Therapeutics' share price is below 20 . This suggests that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 21

 Sell Stretched

 
Oversold
 
Overbought
The successful prediction of Arch Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Arch Therapeutics, which may create opportunities for some arbitrage if properly timed.
Using Arch Therapeutics hype-based prediction, you can estimate the value of Arch Therapeutics from the perspective of Arch Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Arch Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Arch because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Arch Therapeutics after-hype prediction price

    
  USD 1.0E-4  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arch Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.000.0000950.00
Details
Naive
Forecast
LowNextHigh
0.040.040.04
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

Arch Therapeutics After-Hype Price Density Analysis

As far as predicting the price of Arch Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Arch Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Arch Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Arch Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Arch Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Arch Therapeutics' historical news coverage. Arch Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Arch Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.0001
0.0001
After-hype Price
0.00
Upside
Arch Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Arch Therapeutics is based on 3 months time horizon.

Arch Therapeutics Pink Sheet Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Arch Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arch Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Arch Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.0001
0.0001
0.00 
0.00  
Notes

Arch Therapeutics Hype Timeline

Arch Therapeutics is presently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Arch is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Arch Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.02. Arch Therapeutics had not issued any dividends in recent years. The entity had 1:200 split on the 18th of January 2023. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Arch Therapeutics Related Hype Analysis

Having access to credible news sources related to Arch Therapeutics' direct competition is more important than ever and may enhance your ability to predict Arch Therapeutics' future price movements. Getting to know how Arch Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Arch Therapeutics may potentially react to the hype associated with one of its peers.

Arch Therapeutics Additional Predictive Modules

Most predictive techniques to examine Arch price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Arch using various technical indicators. When you analyze Arch charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Arch Therapeutics Predictive Indicators

The successful prediction of Arch Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Arch Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Arch Therapeutics based on analysis of Arch Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Arch Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Arch Therapeutics's related companies.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in Arch Pink Sheet

If you are still planning to invest in Arch Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Arch Therapeutics' history and understand the potential risks before investing.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios